A study of interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-α) serum levels in rats subjected to fecal peritonitis and treated with intraperitoneal ropivacaine

Acta Cir Bras. 2012 Jul;27(7):494-8. doi: 10.1590/s0102-86502012000700011.

Abstract

Purpose: The objective of this study was to assess the cytokine serum levels of IL-6 and TNF-α in rats subjected to fecal peritonitis and treated with peritoneal lavage with 0.2% ropivacaine by peritoneal lavage.

Methods: We subjected 16 Wistar rats to laparotomy 6 hours after the induction of fecal peritonitis with autogenous stool and subsequently divided the rats randomly into 4 groups: I-control, no treatment; II- drying of the abdominal cavity; III- lavage of the abdominal cavity with 3 mL of 0.9% normal saline and drying; IV- lavage of the abdominal cavity with 3 mL of 0.2% ropivacaine and drying. Six hours following the laparotomy, the animals underwent cardiac puncture, and 1 mL of blood was collected for cytokine assessment before the animals were euthanized.

Results: The lavage with ropivacaine resulted in smaller TNF-α levels compared with those observed in the other treatment groups (p <0.05). Regarding IL-6, the ropivacaine group showed lower cytokine levels than those observed in groups I and II, but there was no significant difference (p> 0.05) between groups III and IV.

Conclusion: Peritoneal lavage with 0.2% ropivacaine was shown to reduce plasma levels of IL-6 and TNF-α in the treatment of fecal peritonitis in rats.

MeSH terms

  • Amides / therapeutic use*
  • Anesthetics, Local / therapeutic use*
  • Animals
  • Feces
  • Injections, Intraperitoneal
  • Interleukin-6 / blood*
  • Male
  • Peritoneal Lavage / adverse effects
  • Peritoneal Lavage / methods*
  • Peritonitis / blood*
  • Peritonitis / drug therapy*
  • Random Allocation
  • Rats
  • Rats, Wistar
  • Ropivacaine
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / blood*

Substances

  • Amides
  • Anesthetics, Local
  • Interleukin-6
  • Tumor Necrosis Factor-alpha
  • Ropivacaine